Indication

Infant botulism

Infant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production. Read more about Infant botulism

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Infant botulism therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Infant botulism preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Infant botulism.

Infant botulism is a neuroparalytic disease occurring in infants—predominantly those under six months of age—caused by intestinal colonization with *Clostridium botulinum* spores and subsequent in vivo neurotoxin production.

The absorbed botulinum neurotoxin irreversibly inhibits acetylcholine release at peripheral cholinergic synapses and neuromuscular junctions.

Clinically, it is characterized by an initial onset of constipation followed by symmetric, descending flaccid paralysis.

This typically manifests as bulbar palsies, weak cry, poor feeding, diminished suck and gag reflexes, ptosis, generalized hypotonia, and potentially fatal respiratory failure.

Personalize your experience

Follow Infant botulism and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it